Company: IMRX
Filing Date: 2025-09-24
Form Type: 8-K
Source: 0001104659-25-092957
Chunk: 8

Company: Immuneering Corp
Filing Date: 2025-09-24
Form: 8-K
Item: Item 9.01
Chunk 8
---
Item 9.01. Financial Statements and Exhibits.

(d) Exhibits

  Exhibit No.      Description                                                                                                             
         10.1      Securities Purchase Agreement, dated as of September 24, 2025, by and between Immuneering Corporation and Aventis Inc.  
         99.1      Press Release, dated as of September 24, 2025.                                                                          
 ───────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
          104      Cover Page Interactive Data File (embedded within the inline XBRL document).                                            

SIGNATURES